India’s Sun Pharma gets FDA nod for Optivar generic

MUMBAI, June 22 (BestGrowthStock) – Indian drugmaker Sun
Pharmaceuticals (SUN.BO: ) has received approval from the U.S.
Food and Drug Administration to launch a generic version of
Optivar, used to treat itching of the eyes.

Investing Advice

(Reporting by Sumeet Chatterjee)

India’s Sun Pharma gets FDA nod for Optivar generic